These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38605630)

  • 1. Impact of elevated body mass index (BMI) on cognitive functioning and inflammation in persons with post-COVID-19 condition: a secondary analysis.
    Le GH; Kwan ATH; Guo Z; Wong S; Badulescu S; Gill H; Teopiz KM; Meshkat S; Ceban F; Phan L; Subramaniapillai M; Di Vincenzo JD; Rosenblat JD; Mansur RB; d'Andrea G; Ho R; Rhee TG; McIntyre RS
    Acta Neuropsychiatr; 2024 Apr; ():1-7. PubMed ID: 38605630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vortioxetine for the treatment of post-COVID-19 condition: a randomized controlled trial.
    McIntyre RS; Phan L; Kwan ATH; Mansur RB; Rosenblat JD; Guo Z; Le GH; Lui LMW; Teopiz KM; Ceban F; Lee Y; Bailey J; Ramachandra R; Di Vincenzo J; Badulescu S; Gill H; Drzadzewski P; Subramaniapillai M
    Brain; 2024 Mar; 147(3):849-857. PubMed ID: 37936330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impacts of metabolic disruption, body mass index and inflammation on cognitive function in post-COVID-19 condition: a randomized controlled trial on vortioxetine.
    Kwan ATH; Le GH; Guo Z; Ceban F; Teopiz KM; Rhee TG; Ho R; Di Vincenzo JD; Badulescu S; Meshkat S; Cao B; Rosenblat JD; Dev DA; Phan L; Subramaniapillai M; McIntyre RS
    Ann Gen Psychiatry; 2024 Feb; 23(1):10. PubMed ID: 38424537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Elevated Body Mass Index (BMI) on Hedonic Tone in Persons with Post-COVID-19 Condition: A Secondary Analysis.
    Le GH; Kwan ATH; Wong S; Guo Z; Teopiz KM; Badulescu S; Meshkat S; d'Andrea G; Ho R; Rhee TG; Cao B; Phan L; Rosenblat JD; Mansur RB; Subramaniapillai M; McIntyre RS
    Adv Ther; 2024 Feb; 41(2):686-695. PubMed ID: 38114867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the Effects of Metabolic Disruption, Body Mass Index and Inflammation on Depressive Symptoms in Post-COVID-19 Condition: A Randomized Controlled Trial on Vortioxetine.
    Kwan ATH; Guo Z; Ceban F; Le GH; Wong S; Teopiz KM; Rhee TG; Ho R; Di Vincenzo JD; Badulescu S; Meshkat S; Cao B; Rosenblat JD; d'Andrea G; Dev DA; Phan L; Subramaniapillai M; McIntyre RS
    Adv Ther; 2024 May; 41(5):1983-1994. PubMed ID: 38520501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subjective and Objective Measures of Cognitive Function are Correlated in Persons with Post-COVID-19 Condition: A Secondary Analysis of a Randomized Controlled Trial.
    Kwan ATH; Lakhani M; Le GH; Singh G; Teopiz KM; Ceban F; Nijjar CS; Meshkat S; Badulescu S; Ho R; Rhee TG; Vincenzo JDD; Gill H; McIntyre RS
    medRxiv; 2024 Mar; ():. PubMed ID: 38562707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between fatigue and depressive symptoms in persons with post-COVID-19 condition: a post hoc analysis.
    Teopiz KM; Kwan ATH; Le GH; Guo Z; Badulescu S; Ceban F; Meshkat S; Di Vincenzo JD; d'Andrea G; Cao B; Ho R; Rhee TG; Dev DA; Phan L; Subramaniapillai M; Mansur RB; Rosenblat JD; McIntyre RS
    Curr Med Res Opin; 2024 Jul; 40(7):1203-1209. PubMed ID: 38860901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of vortioxetine on psychosocial functioning moderated by symptoms of fatigue in post-COVID-19 condition: a secondary analysis.
    Badulescu S; Le GH; Wong S; Kwan ATH; Guo Z; Teopiz KM; Phan L; Subramaniapillai M; Rosenblat JD; Mansur RB; McIntyre RS
    Neurol Sci; 2024 Apr; 45(4):1335-1342. PubMed ID: 38321333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Greater Role of Cognitive Impairment Over Fatigue in Post-COVID-19 Quality of Life: A Post-Hoc Analysis of a Randomized Controlled Trial.
    Kwan ATH; Lakhani M; Le GH; Singh G; Teopiz KM; Guo Z; Ceban F; Dhaliwal KK; Badulescu S; Ho R; Rhee TG; Cao B; d'Andrea G; McIntyre RS
    medRxiv; 2024 Mar; ():. PubMed ID: 38562760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between anhedonia and psychosocial functioning in post-COVID-19 condition: a
    Liao S; Teopiz KM; Kwan ATH; Le GH; Wong S; Ballum H; Rhee TG; Badulescu S; Cao B; Guo Z; Meshkat S; Phan L; Subramaniapillai M; Ho R; McIntyre RS
    Curr Med Res Opin; 2024 Jul; ():1-5. PubMed ID: 38954402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of vortioxetine on depressive symptoms moderated by symptoms of anxiety in persons with post-COVID-19 condition: A secondary analysis.
    Le GH; Kwan ATH; Guo Z; Teopiz KM; Wong S; Meshkat S; d'Andrea G; Ho R; Rhee TG; Cao B; Badulescu S; Phan L; Rosenblat JD; Mansur RB; Subramaniapillai M; McIntyre RS
    Psychiatry Res; 2024 Jun; 339():116068. PubMed ID: 38954891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Baseline Anxiety on Well-being in People with Post-COVID-19 Condition: A Secondary Analysis.
    Kleine N; Kwan ATH; Le GH; Guo Z; Phan L; Subramaniapillai M; McIntyre RS
    CNS Spectr; 2024 Apr; 29(2):150-154. PubMed ID: 38453677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perceived Cognitive Deficits in Patients With Symptomatic SARS-CoV-2 and Their Association With Post-COVID-19 Condition.
    Liu TC; Yoo SM; Sim MS; Motwani Y; Viswanathan N; Wenger NS
    JAMA Netw Open; 2023 May; 6(5):e2311974. PubMed ID: 37145596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers of sustained systemic inflammation and microvascular dysfunction associated with post-COVID-19 condition symptoms at 24 months after SARS-CoV-2-infection.
    Jacobs LMC; Wintjens MSJN; Nagy M; Willems L; Ten Cate H; Spronk HMH; van Kuijk SMJ; Ghossein-Doha C; Netea MG; Groh LA; van Petersen AS; Warlé MC
    Front Immunol; 2023; 14():1182182. PubMed ID: 37868959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Vortioxetine on Cognitive Functioning in Working Patients With Major Depressive Disorder.
    McIntyre RS; Florea I; Tonnoir B; Loft H; Lam RW; Christensen MC
    J Clin Psychiatry; 2017 Jan; 78(1):115-121. PubMed ID: 27780334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effects of Vortioxetine on Cognitive Function in Patients with Major Depressive Disorder: A Meta-Analysis of Three Randomized Controlled Trials.
    McIntyre RS; Harrison J; Loft H; Jacobson W; Olsen CK
    Int J Neuropsychopharmacol; 2016 Jun; 19(10):. PubMed ID: 27312740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination after developing long COVID: Impact on clinical presentation, viral persistence, and immune responses.
    Nayyerabadi M; Fourcade L; Joshi SA; Chandrasekaran P; Chakravarti A; Massé C; Paul ML; Houle J; Boubekeur AM; DuSablon C; Boudreau V; Bovan D; Darbinian E; Coleman EA; Vinci S; Routy JP; Hétu PO; Poudrier J; Falcone EL
    Int J Infect Dis; 2023 Nov; 136():136-145. PubMed ID: 37717649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Network Meta-Analysis Comparing Effects of Various Antidepressant Classes on the Digit Symbol Substitution Test (DSST) as a Measure of Cognitive Dysfunction in Patients with Major Depressive Disorder.
    Baune BT; Brignone M; Larsen KG
    Int J Neuropsychopharmacol; 2018 Feb; 21(2):97-107. PubMed ID: 29053849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.